Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Debt Ratio (2016 - 2025)

China Pharma Holdings' Debt Ratio history spans 16 years, with the latest figure at 0.06 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 62.56% year-over-year to 0.06; the TTM value through Dec 2025 reached 0.06, down 62.56%, while the annual FY2025 figure was 0.06, 62.56% down from the prior year.
  • Debt Ratio reached 0.06 in Q4 2025 per CPHI's latest filing, down from 0.12 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.28 in Q3 2022 to a low of 0.06 in Q4 2025.
  • Average Debt Ratio over 5 years is 0.17, with a median of 0.17 recorded in 2024.
  • Peak YoY movement for Debt Ratio: soared 122.79% in 2021, then plummeted 62.56% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.19 in 2021, then dropped by 28.19% to 0.14 in 2022, then grew by 8.06% to 0.15 in 2023, then rose by 14.86% to 0.17 in 2024, then tumbled by 62.56% to 0.06 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Debt Ratio are 0.06 (Q4 2025), 0.12 (Q3 2025), and 0.2 (Q2 2025).